Skip to main content
Log in

The effects of gliclazide in diabetes : a comparison with tolbutamide

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Summary

A STUDY was carried out to examine the effect of Gliclazide on Type I insulin dependent, and Type 2 insulin independent diabetic patients. Both Gliclazide and Tolbutamide increased HDL cholesterol in Type 2 diabetic patients (1.24±0.1→;1.72±0.15 mmol/l, p< 0.05. 1.42±0.1→1.68 ± 0.1 mmol/l, p< 0.05). This improvement appeared to be independent of any improvement in diabetic control in patients on Gliclazide. Gliclazide had no effect on Type 1 diabetic patients on insulin. These results may suggest a protective mechanism for Type 2 maturity onset diabetic patients treated with a sulphonylurea drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Burnstein, M., Scholnick, W. R. 1973. Advances in Lipid Research. Ed. by Paoletti and Kritcheysky. Academic Press, New York, 67–108.

    Google Scholar 

  • Calvert, G. 1978. Effects of therapy on plasma high density lipoprotein cholesterol concentration in diabetes mellitus. Lancet ii, 66–68.

    Article  Google Scholar 

  • Charbonnell, B. 1977. A new approach to the treatment of diabetic disease. Volume Therapeutique des Entretiens de Bichat.i 187–192.

    Google Scholar 

  • Editorial. 1980. Lancet i, 464–465.

  • Kazawosian, M., Riveline, B., Dagrue, G. 1976. Diabetic microangiopathy : study in a department of nephrology during long-term treatment with Gliclazide. Gazette Medicale de France. 83, No. 9.

  • Keen, H. 1970. Minimal diabetes and arterial disease: prevalence and the effect of treatment. Early Diabetes. Ed. by R. Camerini-Davalos, H. Cole. Academic Press, New York.

    Google Scholar 

  • Klaff, L. J., Vinik, A. I., Mahon, E., Kernoff, L., Jacobs, P. 1979. 7ffects of the sulphonylurea drugs Gliclazide and Glibenclamide on blood glucose control and platelet function. South African Med. J. 56, 247–249.

    CAS  Google Scholar 

  • Mattork, M., Fuller, J., Maude, P. S., Keen, H. 1979. Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 34, 437–449.

    Article  Google Scholar 

  • Paasikivi, J. 1970. Long term Tolbutamide treatment after myocardial infarction. Acta Medica Scandanavica. Suppl. vol. 507–517.

  • Ponari, O., Civardi, E., Magha, S., Pini, M., Portioli, D., Dettori, A. G. 1979. Anti-platelet effect of long term treatment with Gliclazide in diabetic patients. Thrombosis Research 16, 191–203.

    Article  PubMed  CAS  Google Scholar 

  • Pyke D. A. 1979. The genetic connections. Diabetologie 17, 333–343.

    Article  CAS  Google Scholar 

  • Welsh, S. G., Boucher, J. 1978. A rapid micros scale method for the measurement of Haemoglobin A1. Diabetologia 14, 209–211.

    Article  Google Scholar 

  • Witzum, J., Schonfeld, S. 1979. High density lipoproteins. Diabetes 28, 326–336.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

We wish to thank Miss R. Bloomgart for carrying out the HbA1 estimation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berber, M.J., Tomkin, G.H. The effects of gliclazide in diabetes : a comparison with tolbutamide. Ir J Med Sci 151, 46–49 (1982). https://doi.org/10.1007/BF02940142

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02940142

Keywords

Navigation